When Elliot Hill took over as the CEO of Nike, about a year ago, he went viral on

LinkedIn because of his resume.

Everyone was just sharing his, you know, job descriptions for the past 37 years, which

is all Nike. He just started as an intern at Nike.

In interviews, he has said that he basically started moving boxes around and taking calls from customers.

And, you know, he rose through the ranks to become an executive.

Last month, our colleague Inti Pacheco flew to Nike's headquarters in Beaverton, Oregon, and sat down with Hill.

I mean, I've certainly my job has changed now as a CEO, and I've had to learn how to be a CEO, which has been, you know, frankly, a bit of a transition, more time with investors, more time with media.

He says that he has an irrational love for the company.

You know, when I was talking to people who know him, they would say that, you know, he gets emotional every time that he talks about the company and the employee base. There are even podcasts where he's like, they ask him about the company and he really just starts like weeping.

For Nike's investors, you could say that there's also been some weeping, but for a completely different reason.

The stock is only worth about

half of what it was three years ago. Nike's had five quarters of consecutive sales declines.

Elliot Hill is the person who has to turn that around. How critical is this moment for Nike?

I think it's an important moment, and I think, you know, the company is starting to show signs of improvement.

But it is like, I think, the point where things could keep improving or maybe things don't work out the way they were expecting. We'll have to wait and see.

Welcome to The Journal, our show about money, business, and power. I'm Ryan Knudsen. It's Tuesday, November 18th.

Coming up on the show, Nike's CEO

and his game plan to turn the company around.

Shouldn't people in the UK enjoy the same access to medical innovation as people elsewhere in the world?

We think so.

But sadly, the UK lags behind, missing out on life-changing treatments for blood cancer, breast cancer, rare disease and for Alzheimer's.

...